Description

The HOYA iSert PY-60AD is a sophisticated intraocular lens (IOL) designed by HOYA Surgical Optics, Inc. to enhance visual outcomes for patients undergoing cataract surgery. This advanced lens is intended for implantation in the capsular bag of the eye, providing a monofocal solution to restore clear vision.

Key Features

• Aspheric Optic Design: The lens features an aspheric, aberration-correcting optic that enhances visual clarity by minimizing optical aberrations.
• UV and Blue Light Filtering: Constructed from hydrophobic acrylic (AF-1) with a yellow tint, the lens filters both UV and blue light, offering additional protection for the eye.
• Sharp Optic Edge: Designed to reduce posterior capsule opacification (PCO), contributing to long-term visual clarity.

Innovative Delivery System

The iSert PY-60AD comes with a fully preloaded injector system, simplifying the implantation process. This single-use device eliminates the need for cleaning and sterilizing reusable injectors, enhancing surgical efficiency and safety.

Material and Configuration

• Optic Material: The lens optic is made from hydrophobic acrylic, while the haptics are composed of blue PMMA, chemically bonded for durability.
• Haptic Design: Features a modified C-loop configuration with 5° angulation, ensuring stable positioning within the eye.

Physical Specifications

• Optic Diameter: 6.0 mm
• Overall Length: 12.5 mm
• Power Range: Available from +6.00 to +30.00 diopters in 0.50 D increments, accommodating a wide range of visual needs.

Manufacturing Excellence

The lens is crafted through a precise lathe-cut and tumble-polished process, ensuring high-quality optical performance. The estimated A-Constant of 118.4 aids in accurate lens power calculations, with optimized constants available for various formulas.

Longevity and Reliability

With an expected lifetime of 20 years, the iSert PY-60AD typically requires no replacement unless medically indicated. While potential adverse events are associated with any IOL, there are no known contraindications for adults, though certain medical conditions may warrant special consideration.

Proven Track Record

Since its launch in 2007, over 10 million of these lenses have been implanted worldwide, demonstrating a strong track record of success. Although there have been reports of haptic damage post-implantation, investigations have found no quality issues with the product.

Handling Instructions

Comprehensive handling instructions are provided for the preloaded injector, ensuring proper preparation and loading, thereby supporting optimal surgical outcomes.